UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy

Cancer chemotherapy and pharmacology, 2011-06, Vol.67 (6), p.1265-1272

2011

Volltextzugriff (PDF)

Phase I study of dasatinib (BMS‐354825) in Japanese patients with solid tumors

Cancer science, 2011-11, Vol.102 (11), p.2058-2064

2011

Volltextzugriff (PDF)

A Japanese post-marketing surveillance of cetuximab (Erbitux®) in patients with metastatic colorectal cancer

Japanese journal of clinical oncology, 2012-04, Vol.42 (4), p.287-294

2012

Volltextzugriff (PDF)

Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis

International journal of hematology, 2011-06, Vol.93 (6), p.745-749

2011

Volltextzugriff (PDF)

Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: Phase II clinical study in Japan

Journal of gastroenterology and hepatology, 2009-02, Vol.24 (2), p.255-261

2009

Volltextzugriff (PDF)

Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia

International journal of hematology, 2009-04, Vol.89 (3), p.332-341

2009

Volltextzugriff (PDF)

Phase II Study of Weekly Paclitaxel for Advanced or Metastatic Breast Cancer in Japan

Anticancer research, 2009-02, Vol.29 (2), p.625-630

2009

Volltextzugriff (PDF)

Phase II Study of Oral Fludarabine Phosphate in Relapsed Indolent B-Cell Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2006-01, Vol.24 (1), p.174-180

2006

Volltextzugriff (PDF)

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection

Journal of hepatology, 2010-06, Vol.52 (6), p.791-799

2010

Volltextzugriff (PDF)

Phase I study of radioimmunotherapy with an anti‐CD20 murine radioimmunoconjugate (90Y‐ibritumomab tiuxetan) in relapsed or refractory indolent B‐cell lymphoma

Cancer science, 2005-12, Vol.96 (12), p.903-910

2005

Volltextzugriff (PDF)

Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy

Hepatology international, 2010-09, Vol.4 (3), p.594-600

2010

Volltextzugriff (PDF)

Erratum to: Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B

Hepatology international, 2010-12, Vol.4 (4), p.789-790

2010

Volltextzugriff (PDF)

Allelotype analysis in relapsed childhood acute lymphoblastic leukemia

Oncogene, 2003-10, Vol.22 (44), p.6970-6976

2003

Volltextzugriff (PDF)

Drug development in Japan from the viewpoints of global pharmaceutical companies

Rinshō ketsueki, 2009-07, Vol.50 (7), p.556

Seriu, Taku

2009

Volltextzugriff (PDF)

Size and composition of T-cell receptor δ (TCRD) junctional sequences are not predictive of the sensitivity of clonospecific oligonucleotides designed for detection of minimal residual disease in acute lymphoblastic leukemia

International journal of hematology, 2003-05, Vol.77 (4), p.371-375

2003

Volltextzugriff (PDF)

Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: Randomized controlled trial in Japanese patients

Journal of gastroenterology and hepatology, 2008-09, Vol.23 (9), p.1320-1326

2008

Volltextzugriff (PDF)

Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia

Leukemia research, 2011-10, Vol.35 (10), p.1345-1349

2011

Volltextzugriff (PDF)

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

The Lancet (British edition), 1998-11, Vol.352 (9142), p.1731-1738

1998

Volltextzugriff (PDF)

Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia

Oncogene, 1999-12, Vol.18 (51), p.7387-7388

1999

Volltextzugriff (PDF)

Pharmacological characteristics and clinical outcomes of ponatinib (Iclusig®), a third-generation tyrosine kinase inhibitor

Folia Pharmacologica Japonica, 2017, Vol.150(1), pp.54-61

2017

Volltextzugriff (PDF)

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL

Blood, 2002-06, Vol.99 (12), p.4386-4393

2002

Volltextzugriff (PDF)

Pooled model-based approach to compare the pharmacokinetics of entecavir between Japanese and non-Japanese chronic hepatitis B patients

Diagnostic microbiology and infectious disease, 2011-05, Vol.70 (1), p.91-100

2011

Volltextzugriff (PDF)

Mutational analysis of the N-ras gene in acute lymphoblastic leukemia : A study of 125 Japanese pediatric cases

International journal of hematology, 1998-06, Vol.67 (4), p.379-387

1998

Volltextzugriff (PDF)

Pharmacological properties and clinical efficacy of abatacept (Orencia®) for the treatment of rheumatoid arthritis

Folia Pharmacologica Japonica, 2011, Vol.137(2), pp.87-94

2011

Volltextzugriff (PDF)

Pharmacological properties and clinical efficacy of abatacept (Orencia(®)) for the treatment of rheumatoid arthritis

Nihon yakurigaku zasshi, 2011-02, Vol.137 (2), p.87-94

2011

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(63)

Sprache

Englisch
(46)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Humans
(40)
Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Biological And Medical Sciences
(25)
Female
(25)
Male
(25)
Medical Sciences
(24)
Middle Aged
(19)
Oncology
(19)
Aged
(16)
Hematology
(16)
Adult
(15)
Child
(15)
Hematologic And Hematopoietic Diseases
(15)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(15)
Adolescent
(9)
Child, Preschool
(9)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Genetics
(9)
All
(8)
Chronic Hepatitis B
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy

Phase I study of dasatinib (BMS‐354825) in Japanese patients with solid tumors

A Japanese post-marketing surveillance of cetuximab (Erbitux®) in patients with metastatic colorectal cancer

Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis

Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: Phase II clinical study in Japan

Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia

Phase II Study of Weekly Paclitaxel for Advanced or Metastatic Breast Cancer in Japan

Phase II Study of Oral Fludarabine Phosphate in Relapsed Indolent B-Cell Non-Hodgkin's Lymphoma

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection

Phase I study of radioimmunotherapy with an anti‐CD20 murine radioimmunoconjugate (90Y‐ibritumomab tiuxetan) in relapsed or refractory indolent B‐cell lymphoma

Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy

Erratum to: Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B

Allelotype analysis in relapsed childhood acute lymphoblastic leukemia

Drug development in Japan from the viewpoints of global pharmaceutical companies

Size and composition of T-cell receptor δ (TCRD) junctional sequences are not predictive of the sensitivity of clonospecific oligonucleotides designed for detection of minimal residual disease in acute lymphoblastic leukemia

Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: Randomized controlled trial in Japanese patients

Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia

Pharmacological characteristics and clinical outcomes of ponatinib (Iclusig®), a third-generation tyrosine kinase inhibitor

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL

Pooled model-based approach to compare the pharmacokinetics of entecavir between Japanese and non-Japanese chronic hepatitis B patients

Mutational analysis of the N-ras gene in acute lymphoblastic leukemia : A study of 125 Japanese pediatric cases

Pharmacological properties and clinical efficacy of abatacept (Orencia®) for the treatment of rheumatoid arthritis

Pharmacological properties and clinical efficacy of abatacept (Orencia(®)) for the treatment of rheumatoid arthritis

Suchergebnisse filtern